摘要
多发性骨髓瘤(MM)是浆细胞克隆性增生的恶性肿瘤,是一种低增殖性、低凋亡活性的分子克隆性疾病,这一特点提示凋亡抑制可能在其发病中发挥了重要的作用。因此,研究MM发病过程中相关的促凋亡基因(蛋白)和抑凋亡基因(蛋白)以及它们之间的相关性,将为MM的分子靶向治疗提供新的策略。
Multiple myeloma (MM) is a clonal plasma cell malignancy, a low proliferative and low apoptotic activity molecular cloning of a disease, which indicates that apoptosis inhibition may play an important role in the pathogenesis of MM. Therefore, the study of MM pathogenesis-related promoting apoptosis genes/proteins and inhibiting of apoptosis genes/proteins, as well as the correlation between them provides a new strategy for molecular targeted therapy.
出处
《白血病.淋巴瘤》
CAS
2010年第8期509-512,共4页
Journal of Leukemia & Lymphoma